Software, hardware, and Data are the drivers of growth and innovation in Cannabis. The Industries’ leading disrupters will discuss their strategies and views, including a focus on DATA, which is helping operators and investors make their decisions for the fist time in our Industry.
Extractions are becoming a massive share of the market in the U.S. Currently, Germany’s medical cannabis patients only have access to flowers. Under the new German laws, extractions will be allowed to be sold in pharmacies. We will go over the most cutting edge, clean and efficient extraction methods and their alternate benefits and discuss how extractions will be implemented into the Hawaiian market.
CLEAN CULTIVATION & GENETICS
With ever tightening regulations and oversight related to Cultivation, our panel of elite Industry scientists and growers will discuss topics ranging from regenerative farming, and breeding, to organic pesticides and microbial screening methods as they relate to more stringent and evolving testing requirements.
LEGAL LANDSCAPE AND RECREATIONAL SALES UNDER TRUMP ADMINISTRATION
Much has been speculated about the course of our Industry under the Trump administration, this panel featuring Industry lobbyists and thought leaders will focus on the road ahead with a special analysis of California’s impending Rec laws slated to go into effect just 30 days after our conference, and in the face of staunch rhetoric from all sides, from both California’s leadership and the Federal Administration, namely AG Sessions.
HAWAII MMJ RULES AND REGULATIONS PANEL
In 2001, Hawaii established a statewide MM caregiver system. In 2015, a dispensary program was established and 8 licenses were awarded on 4 islands. The dispensaries are all vertically integrated, and will produce and distribute all of their own medical marijuana products. In 2018, reciprocation with other state license holders will be allowed. Our panel of local experts will go over the ins and out of the Hawaii MMJ rules and regulations and the trajectory of the industry.
SUNDAY, DEC. 3, 2017
Official Program Guide
KEYNOTE SPEECH Speaker Announcement Coming Soon!
PRIVATE EQUITY, VCs, ANGELS
Private investment has led the way in funding our Industry to this point. Our esteemed panel of Industry financiers will discuss the challenges and nuances of identifying the hottest verticals, and most sought after concepts and companies to invest in.
THE RISE OF LEGITIMATE PUBLIC CANNABIS COMPANIES
We’ll explore Public Markets, and delve into differences between exchanges and advantages relative to private vehicles, for those entrepreneurs considering a go-public strategy, acquisition, or raise from a PubCo. Our panel will feature CEOs from firms with an aggregate market cap north of $1B, who will be sharing their companies’ investment strategies, including North American and International opportunities in Cannabis.
MAINSTREAMING CANNABIS MEDIA
Is there room for Cannabis-centric media in a world that’s increasingly accepting of cannabis and its role in our culture? The recent purchase and valuation of High Times suggests..yes! Our panel of endemic and mainstream media executives will discuss the continued migration of cannabis from counterculture to mainstream and the ‘lanes’ they see possibly existing between the factions of media covering all things cannabis going forward.
INTELLECTUAL PROPERTY & CANNABIS BRANDS
Our panel of distinguished industry legal minds and brand builders will asses how continued social acceptance of cannabis and the industries rising profile and lucrative bottom line is driving brand licensing deals and their relative success. Panelists will also examine and weigh in on the legal ramifications of such deals, and cannabis IP in general, given the murky protections and enforcement associated with our Industry.
Germany has made great strides improving its cannabis laws in recent years, but there is still so much work to be done, as too many patients are still without safe access to a safe medicine. There was understandably great hope that Germany would start treating marijuana the same as any other medicine, after the country...
Despite a little cold and rainy weather, a great crowd turned out this year for the 21st annual Berlin Hanfparade (or “Hemp Parade”) last Saturday, August 12th. According to Michael Knodt, writer for Marijuana.com and speaker at the April 2017 International Cannabis Business Conference in Berlin, the turnout for this year’s event was brimming with...
Despite the nonsensical naysaying by Reefer Madness prohibitionists, medical cannabis now enjoys mainstream acceptance across the United States, (and support is increasing around the world). Whether it be for chronic pain relief, the treatment of post-traumatic stress symptoms, nausea caused by chemotherapy, or a whole host of medical issues, a supermajority of Americans agree that...
I suspect there are smirks emerging as some people are reading this article. “Welcome to the cannabis industry,” they might say. Just five short days following its opening days of sales, Hawaii medical cannabis dispensary Maui Grown Therapies ran out of cannabis – and the company seems a little pissed off. From The Maui News:...
This week scored a mark in history for medical cannabis patients in the Aloha State. Initial sales went into effect on Tuesday on Maui and Wednesday on Oahu at two of the state-licensed dispensaries on the island chain. Although eight dispensaries have been granted licenses by the state’s Department of Health, business owners had been...
Kauai Early Bird Tickets Good Through Nov. 10, 2017